UHLMANN PRICE SECURITIES’s Gilead Sciences GILD Stock Holding History

UHLMANN PRICE SECURITIES’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$505K	Sell	3,994 -495	-11%	-$65.2K	0.02%	141
2026 Q1	$625K	Buy	4,489 +240	+6%	+$33.6K	0.04%	107
2025 Q4	$522K	Buy	4,249 +4	+0.1%	+$486	0.31%	80
2025 Q3	$471K	Buy	4,245 +24	+0.6%	+$2.73K	0.29%	88
2025 Q2	$468K	Sell	4,221 -112	-3%	-$11.9K	0.33%	75
2025 Q1	$486K	Buy	4,333 +39	+0.9%	+$4.02K	0.36%	73
2024 Q4	$397K	Buy	4,294 +6	+0.1%	+$540	0.3%	87
2024 Q3	$359K	Buy	+4,288	New	+$327K	0.29%	95

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UHLMANN PRICE SECURITIES's GILD Position: Q2 2026 in Review

UHLMANN PRICE SECURITIES reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $65.2K and leaving 3,994 shares worth $505K. The position accounts for 0.02% of the portfolio, ranked #141.

UHLMANN PRICE SECURITIES first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $625K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

UHLMANN PRICE SECURITIES held 3,994 shares of Gilead Sciences worth $505K as of Q2 2026.
UHLMANN PRICE SECURITIES sold 495 Gilead Sciences shares in Q2 2026, an estimated $65.2K.
Gilead Sciences made up 0.02% of UHLMANN PRICE SECURITIES's portfolio in Q2 2026, its #141 holding.
UHLMANN PRICE SECURITIES first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
UHLMANN PRICE SECURITIES's Gilead Sciences position peaked at $625K in Q1 2026.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on UHLMANN PRICE SECURITIES's 13F filing for Q2 2026, filed 24 Jul 2026.